Also trades as: CPH.TO (TSX) · $vol 0M
CPHRF OTC
Cipher Pharmaceuticals Inc.
1W: -2.4%
1M: -8.1%
3M: -19.4%
YTD: -11.4%
1Y: -14.2%
3Y: +197.2%
5Y: +441.0%
$9.63
+0.06 (+0.60%)
Weekly Expected Move ±2.9%
$9
$9
$10
$10
$10
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$51M
+53.9% ▲
5Y CAGR: +18.9%
Gross Profit
$34M
+40.1% ▲
5Y CAGR: +12.7%
Operating Income
$17M
+114.1% ▲
5Y CAGR: +6.6%
Net Income
$28M
+140.9% ▲
5Y CAGR: +43.6%
EPS (Diluted)
$1.07
+132.6% ▲
5Y CAGR: +42.8%
EBITDA
$17M
+41.6% ▲
5Y CAGR: +4.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $22M | $21M | $21M | $33M | $51M |
| YoY Growth | +1.6% | -5.8% | +2.4% | +57.7% | +53.9% |
| Cost of Revenue | $4M | $4M | $4M | $9M | $18M |
| Gross Profit | $18M | $17M | $17M | $24M | $34M |
| Gross Margin | 83.2% | 80.7% | 80.8% | 72.2% | 65.8% |
| R&D Expenses | $88K | $98K | $139K | $0 | $0 |
| SG&A Expenses | $5M | $6M | $5M | $12M | $17M |
| Operating Expenses | $6M | $6M | $6M | $16M | $17M |
| Operating Income | $12M | $11M | $12M | $8M | $17M |
| Operating Margin | 53.9% | 53.6% | 54.5% | 23.5% | 32.7% |
| Interest Expense | $92K | $0 | $0 | $0 | $1M |
| Income Before Tax | $11M | $11M | $13M | $3M | $17M |
| Tax Expense | $3M | -$15M | -$8M | -$9M | -$10M |
| Net Income | $8M | $27M | $20M | $12M | $28M |
| Net Margin | 35.4% | 128.8% | 96.3% | 34.6% | 54.2% |
| EPS (Diluted) | $0.29 | $0.99 | $0.80 | $0.46 | $1.07 |
| EBITDA | $14M | $12M | $12M | $12M | $17M |
| Shares Outstanding | 27M | 26M | 25M | 25M | 26M |